Gruppo Oncologico del Nord-Ovest
- Country
- 🇮🇹Italy
- Ownership
- Private
- Established
- 1987-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://gonogroup.org/
FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Drug: FOLFIRIDrug: FOLFOXIRI
- First Posted Date
- 2010-10-13
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Gruppo Oncologico del Nord-Ovest
- Target Recruit Count
- 244
- Registration Number
- NCT01219920
- Locations
- 🇮🇹
A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di Ancona - Ancona (An) Oncologia Medica, Ancona, Italy
🇮🇹Ospedale Civile Ss. Antonio E Biagio Di Alessandria - Alessandria (Al) Oncologia Medica, Alessandria, Italy
🇮🇹Ausl Della Valle D' Aosta (Ao) - Aosta (Ao) Oncologia Medica, Aosta, Italy
First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer
- Conditions
- Colorectal Cancer Metastatic
- Interventions
- First Posted Date
- 2010-07-15
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Gruppo Oncologico del Nord-Ovest
- Target Recruit Count
- 57
- Registration Number
- NCT01163396
Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin
- Conditions
- Squamous Cell Carcinoma of the Head and Neck
- Interventions
- First Posted Date
- 2009-10-22
- Last Posted Date
- 2017-09-05
- Lead Sponsor
- Gruppo Oncologico del Nord-Ovest
- Target Recruit Count
- 282
- Registration Number
- NCT00999700
- Locations
- 🇮🇹
Irccs - Aou S. Martino - Oncology, Genoa, Italy
🇮🇹Irccs - Aou San Martino - Radiotherapy, Genoa, Italy
🇮🇹E.O. Ospedali Galliera, Genova, Italy
Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab
- Conditions
- Colorectal Cancer
- Interventions
- Biological: bevacizumab
- First Posted Date
- 2008-07-22
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Gruppo Oncologico del Nord-Ovest
- Target Recruit Count
- 184
- Registration Number
- NCT00720512
- Locations
- 🇮🇹
Ospedale Santa Croce, Cuneo, Italy
🇮🇹Ospedale degli Infermi - ASL 12, Biella, Italy
🇮🇹Azienda Usl 8 Arezzo, Arezzo, Italy
Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- Biological: bevacizumab
- First Posted Date
- 2008-07-22
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Gruppo Oncologico del Nord-Ovest
- Target Recruit Count
- 509
- Registration Number
- NCT00719797
- Locations
- 🇮🇹
A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di Ancona - Ancona (An) Oncologia Medica, Ancona, Italy
🇮🇹P.O. Zona Aretina - Ospedale S. Donato Di Arezzo - Arezzo (Ar) Oncologia Medica, Arezzo, Italy
🇮🇹Ospedale Della Valdinievole - Pescia (Pt) Oncologia Medica, Pescia, Italy